Medical Equipment

Biochips Market Revenue Expected to Reach $29.02 Billion by 2030 with 14.4% CAGR

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Biochips Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The biochips market size has seen significant growth in recent years. It is anticipated to expand from $14.61 billion in 2025 to $16.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. The historical increase can be attributed to several factors, including the expansion of genomics and proteomics research, the broadening of pharmaceutical and biotech research and development programs, the integration of DNA microarrays in genetic screening, the increasing application of biochips in molecular diagnostics, and the development of analytical platforms based on microarray and microfluidic technologies.

The biochips market size is set to experience substantial expansion in the coming years. It is anticipated to escalate to $29.03 billion in 2030, achieving a compound annual growth rate (CAGR) of 14.4%. This projected growth over the forecast period is fueled by several factors, including the surging demand for personalized therapies and precision medicine, increasing application of lab-on-chip technologies in clinical testing, elevated investment in biomarker discovery and translational research, the broadening uses of biochips across agriculture and life sciences, and the escalating commercialization of sophisticated biochip-based diagnostic instruments. Prominent trends for the forecast period encompass the increasing integration of biochips into genetic sequencing and disease diagnostics, a growing reliance on protein and cell arrays for advanced biomolecular investigations, the rising need for lab-on-chip platforms in point-of-care testing, the wider deployment of biochip applications in drug discovery and development, and a strong emphasis on miniaturization and high-throughput analysis of biological data.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp

What Major Drivers Are Influencing Demand In The Biochips Market?

The biochips market is expected to grow due to the increasing adoption of personalized medicines. Personalized medicine involves customizing medical treatment for individual characteristics, such as genetics or lifestyle, to maximize effectiveness and minimize adverse effects. The rising demand for personalized medicine is fueled by its potential to offer more effective treatments, advances in genomics, the growing complexity of diseases, and regulatory support. Biochips assist in personalized medicine by enabling precise and individualized treatment plans that are tailored to a person’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, which is an increase from six approvals in 2022. Therefore, the expanding use of personalized medicines is a key driver for the growth of the biochips market.

What Major Segment Divisions Exist Within The Biochips Market?

The biochips market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays

2) By Technology: Microarrays, Microfluidics

3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users

Subsegments:

1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays

2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays

3) By Lab-On-Chip: Microfluidic Devices, Biosensors

4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays

5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays

How Are Trends Shaping The Direction Of The Biochips Market?

Leading companies in the biochips market are directing their efforts toward developing advanced technologies, including organ-on-a-chip platforms, with the aim of revolutionizing the processes of drug discovery and development. Organ-on-a-chip platforms are sophisticated microfluidic devices created to simulate the physiological characteristics and functions of human organs in a reduced size. For instance, in April 2024, Boston Micro Fabrication (BMF), a US-based nanotechnology research company, launched BMF Biotechnology Inc. BMF Biotechnology Inc. focuses on Biochips, also known as organ-on-a-chip platforms, which are designed for growing large-scale tissues in vitro. This innovation assists in the faster development of new drugs and cosmetics by offering a platform for testing and research outside the human body.

Which Companies Are Leading Innovation In The Biochips Market?

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

Read the full biochips market report here:

https://www.thebusinessresearchcompany.com/report/biochips-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Biochips Market?

North America was the largest region in the biochips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biochips Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp

Browse Through More Reports Similar to the Global Biochips Market 2026, By The Business Research Company

Fully Automatic Biochemistry Analyzer Market Report 2026

https://www.thebusinessresearchcompany.com/report/fully-automatic-biochemistry-analyzer-global-market-report

Protein Analyzer Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-analyzer-global-market-report

Clinical Chemistry Analyzers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-chemistry-analyzers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795